Articles about Sputnik V

India on Monday reported over 80,000 new COVID-19 cases, a sharp decline of over 25,000 cases from the previous day.

The World Health Organization has sought some more data from Russia's Gamaleya National Research Institute of Epidemiology and Microbiology, developer of COVID-19 vaccine Sputnik V for according Emergency Use Listing status to the jab.

India is considering allowing the mixing of different COVID-19 vaccine doses in what could be the first mix-and-match inoculation.

The Serum Institute of India (SII) will begin producing the Russian COVID-19 vaccine, Sputnik V, from September, the Russian Direct Investment Fund (RDIF) announced today.

Morepen Laboratories has started production of the test batch of Russia's Sputnik V COVID-19 vaccine at its facility in Himachal Pradesh, the Russian Direct Investment Fund (RDIF) and the drug firm said in a statement on Tuesday.

Private hospital chains Fortis Healthcare and Apollo Hospitals have started administering Russian COVID-19 vaccine Sputnik V at two of their hospitals in Delhi-NCR, officials said on Thursday.

The Haryana government on Saturday said that a pharmaceutical company in Malta has expressed interest in supplying the state up to 60 million doses of the Russian COVID-19 vaccine Sputnik V.

Brazil has cleared the proposal to import Bharat Biotech's COVID-19 vaccine, COVAXIN, and Russia's COVID-19 vaccine Sputnik V into the South American country.

A consignment, comprising as many as three million doses of Russia's COVID-19 vaccine Sputnik V, landed at the Rajiv Gandhi International Airport in Hyderabad on Tuesday.

Delhi is likely to receive the first consignment of Sputnik V, the Russian COVID-19 vaccine, after June 20, Delhi Chief Minister Arvind Kejriwal said on Monday.

The government is hopeful of a speedy launch of the single-dose COVID-19 vaccine Sputnik Light in India. All stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application and regulatory approval procedures for the jab to boost the country's vaccination drive.

Chief Minister Arvind Kejriwal on Wednesday said that the manufacturers of Sputnik V have agreed to supply the Russian anti-COVID-19 vaccine to Delhi but its quantity is yet to be decided.

The unprecedented second wave of COVID-19 has brought India's health infrastructure to its knees.

Production of Sputnik V in India is expected to gradually increase to 850 million doses per year, Russian Ambassador to India, N Kudashev said on Sunday.

The Russian COVID-19 vaccine Sputnik Light may reportedly be the first single-dose shot approved in India.

One imported dose of the Russian anti-coronavirus vaccine - Sputnik V - has been priced at Rs. 995.40 in India, Dr. Reddy's Laboratories announced today.

The Union Health Ministry on Thursday announced that Russia's Sputnik V COVID-19 vaccine will be available in markets across the country from early next week.

Health officials in Russia have authorized a single-shot COVID-19 vaccine, Sputnik Light, the developers of the shot said on Thursday.

Dr. Reddy's Laboratories, which has received approval from the Indian drug regulator for restricted emergency use of COVID-19 vaccine Sputnik V, on Tuesday said it expects the first lot of stock from Russian Direct Investment Fund by May end.

The first batch of Russia's COVID-19 vaccine Sputnik V will reach India within the next 10 days.

Earlier this week, India's drug regulator approved Russia's COVID-19 vaccine Sputnik V for restricted use in emergency situations.

Sputnik V, the Russia-made coronavirus vaccine, will be manufactured in India by five pharmaceutical firms. It is estimated that 850 million doses will be produced yearly.

Sputnik V, the COVID-19 vaccine developed by Russia, was reportedly recommended for Emergency Use Authorization (EUA) in India on Monday.

India is likely to have five more COVID-19 vaccines by October this year, top government sources told the news agency ANI.

Stelis Biopharma, the biopharmaceutical arm of Bengaluru-based Strides Pharma Science, will be making and supplying at least 200 million doses of the Sputnik V vaccine, the Russian coronavirus vaccine currently awaiting emergency use approval in India.

Mexico approved the Russian coronavirus vaccine Sputnik V for use on Tuesday, just hours after the publication of early results of an advanced study saying it is about 91 percent effective.

Developers of the Russian coronavirus vaccine Sputnik V on Monday announced signing an agreement with AstraZeneca to test a combination of the British drug maker's COVID-19 shots and a component of the vaccine created in Moscow.

India will reportedly produce around 300 million doses of the Russian COVID-19 vaccine called Sputnik V.

India's friendly neighboring nations trained over 100 experts to strengthen capacities in their countries for facilitating phase-3 clinical trials of the Indian COVID-19 vaccine, a senior official of the Department of Biotechnology said.

Russian President Vladimir Putin on Wednesday ordered authorities to start mass voluntary vaccinations for COVID-19.

India will produce over 100 million doses a year of the Russian COVID-19 vaccine Sputnik V starting 2021, under an agreement between the Russian Direct Investment Fund (RDIF) and Hyderabad-based Hetero Biopharma, Hindustan Times reported.

The Russian vaccine for COVID-19, called Sputnik V, has been found at least 91% effective in the second interim analysis.

Russia's COVID-19 vaccine candidate, called Sputnik V, is expected to start human trials in India soon.

India's Health Minister Dr. Harsh Vardhan said today that deliveries of coronavirus vaccine will happen within a few months, adding that the country's scientists are way ahead in terms of research.

With heartening news of the coronavirus vaccine coming from different parts of the world, the Indian government is trying to understand which one would be the most feasible for the country.

Even as the COVID-19 outbreak has witnessed a downward trend in India, some states have been reporting large spikes in infections, indicating that the pandemic is far from over.

It has been almost a year since the coronavirus pandemic began, yet the virus is far from being brought under control.

Phase II clinical trials for the Russian COVID-19 vaccine, Sputnik V, will have 100 volunteers, the Indian Central Drugs Standard Control Organisation's Drug Controller General (DCGI) has told Sputnik.

Although the coronavirus outbreak in India has started to slow down, the country remains the second worst-hit in the world.

India's drug regulator has refused to allow a large scale clinical trial of Russia's Sputnik V COVID-19 vaccine.